2 results
Approved WMOCompleted
Part A - CX-2009 Monotherapy: Every 21-Day Dosing RegimenThe primary objective of Part A is to determine the safety profile of CX-2009, the maximum tolerated dose (MTD)/recommended Phase 2 dose (RP2D), and the dose-limiting toxicities(DLTs) of CX-…
Approved WMOCompleted
The main purpose of this study is to examine the effects of expiratory muscle strength training (EMST) in subjects who have undergone a total laryngectomy. In this pilot study outcomes in pulmonary function, functional exercise capacity, vocal…